Last 48 quarters of trend data · Healthcare · Biotechnology
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
XOMA Royalty Corp.'s quarterly P/E stands at 46.1x, down 37.2% year-over-year — suggesting improving earnings relative to price. EV/EBITDA has expanded 2731.7% YoY to 347.4x, reflecting rising market expectations or slowing EBITDA growth.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 28.69 | 46.13 | 25.57 | 13.76 | 14.32 | 73.49 | — | — | 4.74 | — | — | — | — |
| — | -37.2% | — | — | +202.2% | — | — | — | — | — | — | — | — | |
| P/S Ratio | 10.07 | 11.09 | 84.00 | 18.69 | 8.52 | 4.61 | 8.93 | 10.77 | 12.20 | 46.73 | 28.96 | 48.69 | 32.66 |
| — | +140.4% | +840.2% | +73.5% | -30.1% | -90.1% | -69.1% | -77.9% | -62.6% | -66.2% | -18.3% | -57.2% | -49.5% | |
| P/B Ratio | 7.25 | 4.84 | 4.63 | 6.48 | 4.84 | 3.47 | 3.80 | 3.66 | 2.76 | 3.38 | 2.39 | 1.53 | 1.97 |
| — | +39.5% | +21.7% | +77.1% | +75.5% | +2.6% | +58.8% | +139.7% | +40.3% | +60.1% | +40.8% | -3.0% | +4.3% | |
| P/FCF | 182.98 | 22.61 | — | — | 17.51 | 33.39 | — | — | 25.29 | — | — | — | — |
| — | -32.3% | — | — | -30.8% | — | — | — | — | — | — | — | — | |
| EV / EBITDA | 39.98 | 347.37 | 43.16 | — | 23.15 | 12.27 | — | — | — | — | — | — | — |
| — | +2731.7% | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | 50.42 | — | 14.42 | 10.64 | 9.80 | 13.62 | — | — | 3.27 | — | — | — | — |
| — | — | — | — | +199.3% | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
XOMA Royalty Corp.'s operating margin was -3.9% in Q1 2026, down 156.3 pp QoQ and down 41.2 pp YoY. The trailing four-quarter average of 42.3% exceeds the current quarter, suggesting the latest result may reflect seasonal weakness or a one-off headwind. Gross margin contracted 4.0% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 94.3% | 92.7% | 100.0% | 90.6% | 95.0% | 96.6% | 90.1% | 100.0% | 100.0% | 99.9% | 98.6% | 97.0% | 97.6% |
| — | -4.0% | +11.0% | -9.4% | -5.0% | -3.3% | -8.7% | +3.1% | +2.4% | +13.9% | +0.5% | +3.7% | +1.8% | |
| Operating Margin | 21.8% | -3.9% | 152.4% | -14.2% | 35.1% | 37.3% | -83.2% | -217.3% | -178.3% | -470.1% | -1087.5% | -697.2% | -359.3% |
| — | -110.5% | +283.1% | +93.5% | +119.7% | +107.9% | +92.3% | +68.8% | +50.4% | +79.8% | -160.2% | +28.1% | +25.9% | |
| Net Margin | 60.8% | 36.2% | 426.2% | 150.3% | 52.5% | 14.9% | -45.5% | -239.6% | 282.7% | -576.8% | -1097.1% | -663.7% | -325.7% |
| — | +143.7% | +1035.9% | +162.7% | -81.4% | +102.6% | +95.8% | +63.9% | +186.8% | +74.3% | -172.8% | +28.4% | +31.4% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 34.1% | 4.1% | 5.8% | 14.0% | 7.8% | 2.8% | -4.8% | -18.7% | 17.5% | -10.0% | -20.7% | -5.1% | -4.8% |
| — | +44.9% | +221.0% | +175.1% | -55.6% | +128.3% | +77.0% | -266.0% | +464.7% | -22.1% | -339.6% | -61.9% | -41.5% | |
| ROA | 12.8% | 1.6% | 2.3% | 5.8% | 3.2% | 1.1% | -1.8% | -7.4% | 6.9% | -3.8% | -11.2% | -4.4% | -4.2% |
| — | +50.4% | +227.6% | +178.1% | -54.3% | +128.8% | +84.1% | -67.5% | +265.9% | +47.1% | -169.0% | -58.6% | -39.7% | |
| ROIC | 6.8% | -0.2% | 1.1% | -0.7% | 2.9% | 4.3% | -6.8% | -16.8% | -10.4% | -8.3% | -22.6% | -5.7% | -6.0% |
| — | -105.7% | +116.1% | +95.8% | +127.5% | +151.6% | +70.1% | -192.5% | -73.8% | +25.9% | -187.0% | +8.9% | +12.6% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
XOMA Royalty Corp.'s Debt/EBITDA ratio is 300.6x, up from 42.9x last quarter — elevated, raising questions about debt serviceability. The current ratio has weakened 35.2% YoY to 3.59x, tightening the short-term liquidity position.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.27 | 1.10 | 1.27 | 1.22 | 1.24 | 1.35 | 1.46 | 1.40 | 1.22 | 1.47 | 1.40 | — | 0.00 |
| — | -18.3% | -13.0% | -12.9% | +1.6% | -8.0% | +3.7% | — | +791669.5% | +244095.5% | +511838.7% | — | -84.4% | |
| Debt / EBITDA | 9.16 | 300.56 | 42.87 | — | 21.78 | 17.67 | — | — | — | — | — | — | — |
| — | +1600.6% | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 3.37 | 3.59 | 3.37 | 3.91 | 4.88 | 5.54 | 5.15 | 7.52 | 8.71 | 9.45 | 8.68 | 3.34 | 5.42 |
| — | -35.2% | -34.7% | -48.0% | -44.0% | -41.4% | -40.7% | +125.4% | +60.7% | +111.7% | -3.3% | -77.3% | -47.7% | |
| Quick Ratio | 3.37 | 3.59 | 3.37 | 3.91 | 4.88 | 5.54 | 5.15 | 7.64 | 8.71 | 9.45 | 8.68 | 3.34 | 5.42 |
| — | -35.2% | -34.7% | -48.8% | -44.0% | -41.4% | -40.7% | +128.7% | +60.7% | +111.7% | -3.3% | -77.3% | -47.7% | |
| Interest Coverage | 3.44 | -0.13 | 3.03 | 5.27 | 3.84 | 1.68 | -7.85 | -3.94 | 5.70 | -1.42 | -12.75 | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying XOMA stock.
XOMA Royalty Corp.'s current P/E is 28.7x. The average P/E over the last 4 quarters is 24.9x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
XOMA Royalty Corp.'s current operating margin is 21.8%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking XOMA Royalty Corp.'s business trajectory between earnings reports.